New York State Common Retirement Fund
CLVS

New York State Common Retirement Fund’s Clovis Oncology, Inc. CLVS Stock Holding History

New York State Common Retirement Fund’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,182
Closed -$2K – 3552
2022
Q2 		$2K Sell
1,182
-66,546
-98% -$98.2K ﹤0.01% 3303
2022
Q1 		$137K Buy
67,728
+84
+0.1% +$165 ﹤0.01% 2951
2021
Q4 		$183K Sell
67,644
-31
-0% -$115 ﹤0.01% 2904
2021
Q3 		$302K Sell
67,675
-18,323
-21% -$88.2K ﹤0.01% 2726
2021
Q2 		$499K Buy
85,998
+19,798
+30% +$116K ﹤0.01% 2590
2021
Q1 		$465K Hold
66,200
– – ﹤0.01% 2492
2020
Q4 		$318K Hold
66,200
– – ﹤0.01% 2568
2020
Q3 		$386K Hold
66,200
– – ﹤0.01% 2340
2020
Q2 		$447K Buy
66,200
+43,400
+190% +$329K ﹤0.01% 2278
2020
Q1 		$145K Sell
22,800
-22,600
-50% -$181K ﹤0.01% 2616
2019
Q4 		$473K Sell
45,400
-2,700
-6% -$19.6K ﹤0.01% 2323
2019
Q3 		$189K Hold
48,100
– – ﹤0.01% 2800
2019
Q2 		$715K Sell
48,100
-6,927
-13% -$125K ﹤0.01% 2190
2019
Q1 		$1.37M Buy
55,027
+3,593
+7% +$90.1K ﹤0.01% 1801
2018
Q4 		$924K Sell
51,434
-1,566
-3% -$32K ﹤0.01% 1959
2018
Q3 		$1.56M Hold
53,000
– – ﹤0.01% 1835
2018
Q2 		$2.41M Buy
53,000
+4,700
+10% +$229K ﹤0.01% 1585
2018
Q1 		$2.55M Hold
48,300
– – ﹤0.01% 1498
2017
Q4 		$3.28M Sell
48,300
-650
-1% -$45.4K ﹤0.01% 1405
2017
Q3 		$4.03M Sell
48,950
-1,843
-4% -$146K 0.01% 1308
2017
Q2 		$4.76M Sell
50,793
-928
-2% -$56.8K 0.01% 1296
2017
Q1 		$3.29M Buy
51,721
+11,939
+30% +$726K ﹤0.01% 1431
2016
Q4 		$1.77M Hold
39,782
– – ﹤0.01% 1765
2016
Q3 		$1.43M Hold
39,782
– – ﹤0.01% 1826
2016
Q2 		$546K Buy
39,782
+7,200
+22% +$105K ﹤0.01% 2247
2016
Q1 		$626K Hold
32,582
– – ﹤0.01% 2160
2015
Q4 		$1.14M Sell
32,582
-1,693
-5% -$109K ﹤0.01% 1894
2015
Q3 		$3.15M Buy
34,275
+2,689
+9% +$233K 0.01% 1394
2015
Q2 		$2.78M Buy
31,586
+25,675
+434% +$2.2M ﹤0.01% 1692
2015
Q1 		$439K Buy
+5,911
New +$417K ﹤0.01% 2055

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

New York State Common Retirement Fund's CLVS Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 1,182 shares — an estimated $2K sold.

New York State Common Retirement Fund first reported a position in CLVS in Q1 2015 and held it in 30 quarters. The position peaked at $4.76M in Q2 2017. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,182 Clovis Oncology, Inc. shares in Q3 2022, an estimated $2K.
  • New York State Common Retirement Fund first reported a position in Clovis Oncology, Inc. in Q1 2015 and held it in 30 quarters.
  • New York State Common Retirement Fund's Clovis Oncology, Inc. position peaked at $4.76M in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.